Details of Viral Vaccine
This Viral vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 10360 |
| Vaccine Name | Motavizumab |
| Disease Name | Respiratory syncytial virus infection |
| Disease Classification | Respiratory |
| Virus Name | Respiratory syncytial virus |
| Nucleic Acid Content | negative-sense, single-stranded RNA |
| Vaccine Type | Protein subunit |
| Vaccine Status | Phase 3 |
| Manufacturer | MedImmune LLC |
| Year of Manufacturing | 2013 |
| Manufacturing Country | USA |
| Age | upto 1 year |
| Dosage | 5 doses in interval for 1 month |
| Administration Route | Intramuscular |
| Adjuvant | NA |
| Target Strain | Fusion glycoprotein of RSV |
| Description | NA |
| Approving Organisation | NA |
| Collaborating Organisation | NA |
| Other Countries | NA |
| Trade Name | NA |
| PMID | NA |
| Clinical Trial ID | NCT00129766 |
| Reference Link | https://clinicaltrials.gov/ct2/show/NCT00129766?recrs=bde&cond=Respiratory+Syncytial+Virus+%28RSV%29&phase=23&draw=2&rank=3 |
| Additional Links | NA |